SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

The Grand Luna feature a stainless-steel lid hand-finished at Campfire’s workshop, while the earpieces themselves feature a Campfire Audio logo and a textured stainless-steel finish.

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

Canonical's OpenJDK builds promise Java devs more speed - and a whopping 12 years of security support The company is also aligning Ubuntu's and OpenJDK's release cadences.

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

This latest version of Java, due to arrive as a production release on September 16, has 18 features. JDK 25 comes on the heels of JDK 24, a six-month-support release that arrived March 18.